Wistar rats (25/ sex group) and CD-1 mice (30Isex group) were fed either a control diet or diet supplemented with N,N-dimethylformamide at the levels of 215, 750, and 2500 ppm for rats and 160,540, and 1850 ppm for mice. The duration of feeding was 104 days for rats and 119 days for mice. Body weight gain, food consumption, hematological and clinical chemical data, ophthalmic, gross, and microscopic examinations were used to study possible toxic or pathologic effects. A significant reduction in body weight gain was noted for male and female rats at the high dosage level. Food consumption in male rats at the high-dosage level and female rats at both the middle-and high-dosage levels was decreased. A significant dose-related increase in relative liver weights was noted in male and female rats. Absolute liver weights of male rats were comparable among groups, however, a dose-related increase was noted in female rats. No significant differences among groups were noted in body weight and food consumption data for mice. A significant dose-related increase in relative and absolute liver weights was noted in male and female mice.
INTRODUCTION
N-DIMETHYLFORMAMIDID (CAM 68-12-2) is a clear, colorless, essentially neutral, nonhydroxylic, lv aprotic solvent with a high dielectric constant. It is completely miscible in water, ether, alcohols, esters, ketones, and chlorinated and aromatic hydrocarbons, but it has limited solubility in aliphatic hydrocarbons. The metabolism of dimethylformamide was first studied in rats and dogs (Barnes and Ranta, 1972; Kimmerle and Eben, 1975) and was found to consist of a progressive demethylation, possibly followed by hydrolysis of the amide bond. Barnes and Ranta (1972) found that in liver homogenates (in vitro), enhancement of the demethylation occurred when N-demethylase was induced in the liver by phenobarbital. The monoethyl derivative, N-methylformamide, was found to be the main urinary metabolite.
N,N-dimethylformamide has recently been proposed for use as an inert ingredient in agricultural chemical products, thus, the oral route of administration is appropriate. The present study was conducted to evaluate the effects of feeding N,N-dimethylformamide at dose levels up to 2500 ppm to Wistar rats for 104 consecutive days and to 1850 ppm to CD-1 mice for 119 consecutive days.
METHODS

Animals and Materials
Wistar rats (FDRL, Wistar derived) and CD-I mice (Charles River Breeding Laboratories, lnc., Wilmington, MA) were used. Animals were 6-8 weeks of age at the time of the start of the experiment and were individually housed in wire mesh-bottom cages in environment-controlled rooms (one species per room) artificially illuminated for 12 hr each day and maintained at 20-24°C. All animals were given Charles River RMH Formula 3200 meal (Agway, Waverly, NY) and tap water ad libitum. N,N-dimethylformamide (technical grade) was obtained from E.I. DuPont de Nemours 8z Co., Wilmington, DE and was 99.9% pure with a water content of 0.015% and a dimethylamine content of 6 ppm.
Experimental Design
The dose levels of N,N-dimethylformamide were 0, 215, 750, and 2500 ppm for rats and 0, 160, 540, and 1850 ppm for mice. The test diets were prepared by incorporating an appropriate amount of N,N-dimethylformamide into rat feed using a Hobart blender. Diets were prepared fresh each week and stored at room temperature until used.
Each dose group consisted of either 25 male and 25 female rats or 30 male and 30 female mice. Rats and mice were fed either the control diet or diet supplemented with N,N-dimethylformamide for either 104 or 119 consecutive days, respectively. Animals were weighed and food consumption was measured weekly. Body weight gain/100 g of food consumed (food conversion) and compound consumption were calculated. Animals were observed daily for behavior and external signs of N,Ndimethylformamide toxicity. Gross ophthalmic examinations were conducted by a veterinary ophthalmologist on each animal at initiation and termination of the study.
Blood samples for hematologic and clinical chemical determinations were collected from rats after 30 and 90 days of dosing. For mice, blood samples for hematologic determinations were collected after 30 and 90 days of dosing, and for clinical chemical determinations only after 90 days. Animals were fasted overnight prior to collection; blood was obtained from the periorbital plexus. Hematocrit, erythrocyte count, total and differential leukocyte count, platelet count, reticulocyte count, erythrocyte sedimentation rate, and level of hemoglobin were determined on five rats or mice per sex per group. Levels of glucose, urea nitrogen, total protein, bilirubin, sodium, potassium chloride and activities of glutamate pyruvate transaminase, glutamate oxaloacetate transaminase, and alkaline phosphatase were determined on five rats per sex per group or on five pooled samples per sex per group for mice. Each pooled sample was obtained from five different mice from that group. Urine was collected from five rats or mice per sex per group after 30 and 90 days of dosing and measurements of pH, specific gravity, color, appearance, ketones, protein, bilirubin, occult blood, as well as microscopic examinations were made.
All surviving rats and mice were killed using chloroform vapors after 104 or 119 days of feeding, respectively. Selected organs (brain, pituitary gland, heart, thyroid gland, liver, kidneys, spleen,
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adrenal glands, testes, and ovaries) were weighed. For all control and high-dose animals, the organs or tissues that were taken for histopathology included the organs weighed as well as the following: lungs, lymph node (mesenteric), stomach, pancreas, small and large intestine, urinary bladder, mammary gland, epididymides, uterus, sternum (with marrow), sciatic nerve, skeletal muscle, spinal cord, eyes, and grossly abnormal tissues. For the low-and middle-dosage groups, the tissue and organs mentioned above were examined from five animaldsex group.
Statistical Analysis
Body weight, food consumption, food conversion, organ weight, and clinical data were evaluated using analysis of variance followed by Tukey's multiple range test (Steel and Torrie, 1960) . Doseresponse relationships were determined using least-squares regression analysis (Snedecor and Cochran, 1967) . Ophthalmologic and pathologic incidence data were analyzed using a Chi-square test (2 x 2 contingency table) with Yates' correction for continuity (Snedecor and Cochran, 1967) .
RESULTS
Rat Study
A significant reduction in body weight gain over the course of the study was noted for male and female rats at the high-dosage level in comparison to respective control rats (Table 1) . Over the 104day study period, food consumption in male animals at the high-dosage level and female animals at both the middle-and high-dosage levels was decreased in comparison to respective control rats. However, food conversion of male and female rats was comparable among groups.
At the termination of the study, the hematocrit of male animals at the low-dosage level was significantly less than that of control animals (37 f 3% vs. 42 f 2%). No other statistically significant differences were noted among groups at either sampling period. All of the mean hematology values, including the hematocrit of low-dose males, were within the normal physiological range for rats. No significant differences were noted in any of the urine variables measured at either sampling period, A statistically significant increase in sodium levels of male rats in the high-dosage group was noted 
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in comparison to control rats (150 f 5 mEq/liter vs. 140 f 2 mEq/liter) at the termination of the study. All other variables were comparable among groups at both sampling periods. All of the mean chemistry values including sodium were within the normal physiological range for rats. No gross or microscopic effects of N,N-dimethylformamide on ocular tissues were noted at levels up to 2500 ppm in the diet.
An increase ( p < 0.05) in brain and testes to body-weight ratios was noted in male rats at the highdosage level in comparison to control rats (Table 2) . Absolute brain and testes weights of male rats were comparable among groups.
A dose-related increase in liver to body-weight ratios was noted in male ( r = 0.925, NS) and female ( r = 0.978, p c 0.05) rats ( Table 2) . Absolute liver weights of male rats were comparable among groups. However, a dose-related increase in absolute liver weights was noted in female rats ( r = 0.962, p c 0.05).
One male low-dosage level animal died during the third week of the study. The cause of death a p peared to be acute pneumonitis with multiple lung abscesses. Five other animals died; their deaths were related to the blood collection procedure. Histopathological evaluation revealed no evidence of an effect related to feeding of N,N-dimethylformamide. Statistical analysis of these data showed that the incidence of each type of lesion in any group was comparable to that in the control group.
Mouse Study
No significant differences among groups were noted in body-weight gain, food consumption, and food conversion data during the 119-day feeding period (Table 3) . Animal behavior and physical appearance were normal for all mice during the study period. Ophthalmic examinations revealed no gross or microscopic treatment-related effects.
Glutamate pyruvate transaminase levels of high-dose female mice were significantly increased no lesions in these organs were noted as test effects. Microscopic examination o f these, as well as other tissues and organs, did not reveal any treatment-related effects. Lesions observed in N,Ndimethylformamide-treated animals were comparable to those found in control rats or mice and in historical control animals.
